Caribou Biosciences, Inc. (CRBU) bonds
CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3075% below fair value
$0.33−0.01 (-4.29%)
Close on Nov 18, 2026Market cap $34.96MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Caribou Biosciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Caribou Biosciences's 10-Q for the period ended May 6, 2020
Caribou Biosciences's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| PPP Loan | – |
See a number that looks wrong?